BUCHAREST (Romania), September 19 (SeeNews) – Romania's pharmaceuticals market expanded by 16.3% on the year to 3.29 billion lei ($830 million/739 million euro) for the second quarter of 2016, mostly due to a subsidized sales of a new Hepatitis C drug, a survey by market researcher Cegedim Romania showed on Monday.